Safe Biologics

JUNE 12, 2023

Mr. Spiegel is a founding member of ASBM and Executive Director of the Global Colon Cancer Association. The paper is authored by IFA Secretary-General Jane Barratt and ASBM Executive Director Michael Reilly. View the webinar here.

Biosimilars 100

Biosimilars Drug Pricing Compounding Drug Development 100

Express Pharma

MARCH 12, 2024

The Government has rolled out the Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024. Promotional materials, including mailings and journal advertisements, must be clearly identifiable and conform to standards of good taste. They should not mimic editorial content and must provide accurate information about the product.

Hospitals 110

Hospitals 110

European Pharmaceutical Review

NOVEMBER 27, 2023

NICE’s recommendation means that “babies born with Wolman Disease and their parents access to a new treatment option,” Bob Stevens, Group Chief Executive of the MPS Society commented. Evidence of successful long-term management of the disease was reported in a case study published last year in the Canadian Liver Journal.

Hospitals 95

Hospitals 95

European Pharmaceutical Review

NOVEMBER 28, 2023

The FDA’s approval of Ogsiveo is based on results from the Phase III DeFi clinical trial , which were published this year in the New England Journal of Medicine. The post First pill for desmoid tumours approved appeared first on European Pharmaceutical Review. Patients were randomised to receive 150mg of Ogsiveo or placebo. .

Labelling 83

Labelling 83

pharmaphorum

NOVEMBER 7, 2022

With more than a decade of experience leading and scaling managed care organisations, Grabski is a seasoned business leader and finance executive. He has also served as VP of Strategy and Execution, primarily responsible for adapting UHC’s Medicare Advantage business to the changes from the ACA. billion in revenue and 300 FTEs.

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies 105

Safe Biologics

FEBRUARY 1, 2024

ASBM Featured in WHO Executive Summary of 77th INN Consultation On January 18th, the World Health Organization published the Executive Summary of its 77th Consultation on International Non-proprietary Names for Pharmaceutical Substances (INN), held in Geneva, Switzerland on October 18th, 2023.

Biosimilars 130

Biosimilars Documentation Drug Pricing 130

European Pharmaceutical Review

JULY 25, 2023

. “[It] is the first investigational chronic GVHD treatment to target inflammation and fibrosis through the inhibition of disease associated macrophages,” stated Michael A Metzger, Chief Executive Officer of Syndax Pharmaceuticals. Phase I/II data for axatilimab in GVHD has been published in the Journal of Clinical Oncology.

97

97

European Pharmaceutical Review

JANUARY 4, 2024

The post Novel drug delivery method shows promise in Alzheimer’s appeared first on European Pharmaceutical Review. Focused ultrasound therefore has “great promise for improving drug delivery to the brain” he added. Yet several barriers in the body must be overcome to reach its target site, such as the blood-brain barrier.

73

73

European Pharmaceutical Review

NOVEMBER 27, 2023

NICE’s recommendation means that “babies born with Wolman Disease and their parents access to a new treatment option,” Bob Stevens, Group Chief Executive of the MPS Society commented. Evidence of successful long-term management of the disease was reported in a case study published last year in the Canadian Liver Journal.

Hospitals 59

Hospitals 59

pharmaphorum

JULY 21, 2022

The pharmaceutical industry has long been highly regulated to help ensure quality and safety across all aspects of its business. Implementing Pharmaceutical Quality systems. If pharmaceutical companies have a fully operational and robust quality system, they will likely always be compliant with their region’s regulations.

Biosimilars 98

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 98

European Pharmaceutical Review

MAY 24, 2023

Data from the Phase III (GEM-3) trial, published in the New England Journal of Medicine , demonstrated achievement of complete wound healing at six months and complete wound healing at three months. The post First redosable gene therapy approved appeared first on European Pharmaceutical Review. The “landmark approval” declared Krish S.

96

96

European Pharmaceutical Review

FEBRUARY 22, 2023

“Today’s approval offers physicians and patients in the EU more flexibility to determine the right treatment plan and enables more patients to potentially benefit from this medicine,” explained Dave Fredrickson, Executive Vice President of AstraZeneca’s Oncology Business Unit.

84

84

European Pharmaceutical Review

JANUARY 20, 2023

The safety profile of donanemab was initially reported from the TRAILBLAZER-ALZ trial in the New England Journal of Medicine. ” First virtual clinical trial examines two promising Alzheimer’s drugs The post FDA issues complete response letter for donanemab appeared first on European Pharmaceutical Review. .

86

86

European Pharmaceutical Review

JULY 17, 2023

The data was shared at the 2023 Alzheimer’s Association International Conference (AAIC) and published in the Journal of the American Medical Association (JAMA). The post New data suggests novel mAb could delay progression of early Alzheimer’s appeared first on European Pharmaceutical Review.

87

87

European Pharmaceutical Review

JANUARY 26, 2023

The trial results were presented at the American Society of Clinical Oncology 2022 Annual Meeting and published in The New England Journal of Medicine. The post Enhertu approved in EU for HER2-low breast cancer appeared first on European Pharmaceutical Review.

Chemotherapy 79

Chemotherapy 79

European Pharmaceutical Review

AUGUST 1, 2022

A study published in the Journal of the American Medical Association found that 12.4 The DDiCT initiative aligns with the pharmaceutical company’s broader diversity and inclusion goals for 2020-2025, which aim to address health disparities, clinical trial diversity, supplier diversity, employee giving and workforce representation. “All

Drug Development 109

Drug Development Pharmaceutical Companies Pharmaceutical Companies 109

The Honest Apothecary

MAY 3, 2023

. “Research published in the Journal of the American Medical Association (JAMA) Internal Medicine found that a chatbot’s responses to patient questions, pulled from a social media platform, were rated “significantly higher for both quality and empathy.” ’ MANAGED HEALTHCARE EXECUTIVE.

Specialty Pharmacies 105

Specialty Pharmacies Hospitals 105

PharmaState Academy

MARCH 5, 2024

CASE STUDY Setting Realistic Goals and Deadlines Enhancing Time Management in Pharmaceutical Sales Table of Contents Case Study Introduction: Effective time management is crucial for success in pharmaceutical sales, where professionals must navigate competing priorities, customer demands, and dynamic market conditions.

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

OCTOBER 19, 2022

He has held executive positions with several Fortune 500 companies and has been a featured thought leader in publications including CIO, WIRED, Forbes, Knowledge@Wharton, Los Angeles Times and The Wall Street Journal. Timothy White is the global head of digital at Teva Pharmaceuticals. Tim White, global head of digital, TEVA.

98

98

European Pharmaceutical Review

DECEMBER 12, 2023

Yannis Morel, Executive Vice President of product portfolio strategy and business development of Innate Pharma SA, offers insight on engineering antibodies to develop antibody-based NK cell therapeutics. Detailed results from COAST were published in the Journal of Clinical Oncology in 2022.

Immunity 107

Immunity Immunization Chemotherapy Pharmaceutical Companies 107

LifeProNow

MARCH 20, 2023

We are therefore delighted that patients in China will now have a new treatment option for metastatic hormone-sensitive prostate cancer that delays disease progression, extends survival and maintains quality of life”, said Christine Roth, Member of the Executive Committee of Bayer’s Pharmaceuticals Division and Head of the Oncology SBU at Bayer.

Compounding 100

Compounding Pharmaceutical Companies Pharmaceutical Companies 100

European Pharmaceutical Review

SEPTEMBER 29, 2022

The US Food and Drug Administration (FDA)’s Center for Drug Evaluation and Research (CDER) through the Office of Pharmaceutical Quality in 2021 embarked on an initiative to develop a framework for establishing a pharmaceutical manufacturing site quality rating system, the Quality management maturity (QMM) programme.

Nursing Homes 77

Nursing Homes Pharmaceutical Manufacturing Department of Veterans Affairs Dosage 77

European Pharmaceutical Review

SEPTEMBER 26, 2022

Results published in The New England Journal of Medicine (NEJM) suggested marked improvement for patient quality of life, even in those with mild symptoms, hence the EC’s acceptance of the additional therapy. The trial evaluated the safety and efficacy of Ultomiris in 175 adult patients over a 26-week period.

Immunity 68

Immunity Immunization Communication 68

Safe Biologics

JANUARY 1, 2023

drug distribution system, with an emphasis on payer and pharmaceutical benefit manager (PBM) practices regarding biologic medicines and biosimilars. Upon completion, students will be able to: Discuss the role of pharmaceutical benefit managers (PBMs) in the U.S. The paper was published in GaBI Journal, Volume 11, Year 2022, Issue 3.

Biosimilars 100

Biosimilars Drug Pricing 100

pharmaphorum

MARCH 18, 2022

AstraZeneca (AZ), GlaxoSmithKline (GSK), Sanofi, Allergan and Britannia Pharma have been reprimanded for running advertisements that breached the Association of British Pharmaceutical Industry (APBI) code of practice. The post Latest ABPI code breaches reveal the risk of ‘likes’ on LinkedIn appeared first on.

Vaccines 64

Vaccines 64

pharmaphorum

MAY 26, 2022

Ukrainian pharmaceutical companies are struggling to perform their duties in pharmacovigilance as Russia launched a wide-scale war in Ukraine. Russia’s full-scale invasion of Ukraine has already affected the global pharmaceutical industry a lot. This platform made work easier for many pharmaceutical companies.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Documentation 52

PharmaShots

MARCH 9, 2023

Other Affiliations: Presently, Aida serves as an Executive Board Member for the International Science Reserve in The New York Academy of Sciences Board of Governors. Designation: Chief Executive Officer (CEO) and Chair of the Executive Board Previous company: Sanofi (8 yrs.) LinkedIn Total experience: 26 yrs.

Clinical Pharmacology 40

Clinical Pharmacology Immunity Immunization Pharmaceutical Companies 40

Safe Biologics

DECEMBER 8, 2022

The presentation reflected the findings from a recent webinar ASBM held on this subject with GaBI Journal. Read the GaBI Journal report of the webinar here. ASBM Advisory Board Chair Philip Schneider, MS, FASHP, FFIP gave a presentation entitled “Key Factors for Improving Sustainability in Biosimilar Markets”. 11% were unsure.

Biosimilars 100

Biosimilars Communication Drug Development 100

LifeProNow

MAY 8, 2023

Marc Dunoyer, Chief Executive Officer, Alexion, said: “ Koselugo offers hope for children whose quality of life and overall well-being is impacted by the growth of painful, debilitating tumours throughout the body.

Adverse Reactions 100

Adverse Reactions Hospitals 100

pharmaphorum

JANUARY 27, 2022

The last chapter in Applied Virtual Reality in Healthcare, entitled “A Virtual Reality Platform for the Objective Measurement of Emotional State,” highlights potential obstacles ahead and examines how pharmaceutical companies can help address these issues. For example, mental health disorders and cognitive decline are rising.

Chemotherapy 142

Chemotherapy Pharmaceutical Companies Pharmaceutical Companies 142

pharmaphorum

OCTOBER 13, 2021

They will take responsibility for the accuracy and quality of the digital publication, direct the implementation of the editorial strategy and content plan by engaging with the in-house editorial team / freelancers / external partners to develop and execute high quality content for the website and its associated publications. Creative mind.

Communication 52

Communication 52

pharmaphorum

OCTOBER 13, 2021

The web editor is responsible for driving the editorial strategy and content plan (excluding the news channel) for pharmaphorum.com through engaging with the editorial team / freelancers / external partners to develop and execute high quality content for the website and its associated publications. BSc/BA in journalism or relevant field.

Communication 40

Communication 40

GMPSOP

FEBRUARY 10, 2024

GMP training for employees – essential steps The development, implementation and execution of employees’ GMP training can vary depending on business operations and respective regulatory expectations. – Forward the original training record to the Training Administrator for record-keeping and archiving. </p>

Health and Personal Care Stores 52

Health and Personal Care Stores Documentation Packaging Compounding 52

Viseven

OCTOBER 26, 2022

The pharmaceutical industry still faces significant challenges and is looking for innovative solutions. Below are five of the most significant pharmaceutical industry problems. . Therefore, to reduce the challenges of their pharmaceutical supply chain, they changed their strategy and made the most use of the resources available.

Hospitals 52

Hospitals Vaccines Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

DECEMBER 11, 2022

So, when a life sciences company embarks on a project of digital transformation or innovation, it’s really embarking on multiple projects that span the wide world of pharmaceutical operations. In 2019, he was awarded “Excellence in Medical Affairs Award” by the Association of Pharmaceutical Medicine Singapore (APMS).

Hospitals 137

Hospitals 137

Putting Patients First Blog

NOVEMBER 14, 2023

4,5,6 Efficient transaction and customer support services are essential for the seamless exchange of data between pharmaceutical supply chain entities when dispensing selected drugs. Rutta Chief Executive Officer 1 Mello, M. Journal of Managed Care & Specialty Pharmacy, 27(7), 903-907. Sincerely, Randall L. Blendon, R.,

Drug Pricing 40

Drug Pricing HIPAA Specialty Pharmacies Payment Processing 40

Putting Patients First Blog

FEBRUARY 6, 2024

Studies show that an increase in National Institutes of Health (NIH) funding levels leads to a substantial rise in private pharmaceutical research and development spending, highlighting the catalytic effect of federal funding in medical research. Orphanet Journal of Rare Diseases, 13(196). Sincerely, Randall L. 7 Cleary, E.,

Communication 40

Communication Documentation Drug Development 40